Display options
Share it on

Biol Blood Marrow Transplant. 2012 Feb;18(2):183-9. doi: 10.1016/j.bbmt.2011.07.022. Epub 2011 Jul 30.

Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Ellen M Denzen, Martha E Burton Santibáñez, Heather Moore, Amy Foley, Iris D Gersten, Cathy Gurgol, Navneet S Majhail, Ryan Spellecy, Mary M Horowitz, Elizabeth A Murphy

Affiliations

  1. National Marrow Donor Program, Patient Services, 3001 Broadway Street NE, Minneapolis, MN 55413, USA. [email protected]

PMID: 21806948 PMCID: PMC3242929 DOI: 10.1016/j.bbmt.2011.07.022

Abstract

Informed consent is essential to ethical research and is requisite to participation in clinical research. Yet most hematopoietic cell transplantation (HCT) informed consent forms (ICFs) are written at reading levels that are above the ability of the average person in the United States (U.S.). The recent development of ICF templates by the National Cancer Institute, National Institutes of Health, and the National Heart Blood and Lung Institute have not resulted in increased patient comprehension of information. Barriers to creating Easy-to-Read ICFs that meet U.S. federal requirements and pass institutional review board (IRB) review are the result of multiple interconnected factors. The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) formed an ad hoc review team to address concerns regarding the overall readability and length of ICFs used for BMT CTN trials. This paper summarizes recommendations of the review team for the development and formatting of Easy-to-Read ICFs for HCT multicenter clinical trials, the most novel of which is the use of a 2-column format. These recommendations intend to guide the ICF writing process, simplify local IRB review of the ICF, enhance patient comprehension, and improve patient satisfaction. The BMT CTN plans to evaluate the impact of the Easy-to-Read format compared with the traditional format on the informed consent process.

Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

References

  1. J Am Board Fam Pract. 1992 May-Jun;5(3):257-64 - PubMed
  2. Patient Educ Couns. 2009 Jun;75(3):352-7 - PubMed
  3. J Natl Cancer Inst. 1998 May 6;90(9):668-74 - PubMed
  4. N Engl J Med. 1999 Jul 1;341(1):14-21 - PubMed
  5. J Clin Oncol. 2003 Mar 1;21(5):836-42 - PubMed
  6. J Cancer Educ. 1996 Spring;11(1):32-8 - PubMed
  7. J Am Optom Assoc. 1982 Jan;53(1):43-50 - PubMed
  8. Patient Educ Couns. 2002 Jan;46(1):31-8 - PubMed
  9. Crit Care Med. 2001 Feb;29(2):235-41 - PubMed
  10. J Clin Oncol. 2007 Mar 20;25(9):e13-4 - PubMed
  11. Cancer Invest. 2001;19(4):437-45 - PubMed
  12. Cancer Nurs. 2002 Apr;25(2):81-7 - PubMed
  13. Arch Pediatr Adolesc Med. 2005 Apr;159(4):347-52 - PubMed
  14. J Clin Oncol. 1994 Oct;12(10):2211-5 - PubMed
  15. Bone Marrow Transplant. 1990 Dec;6(6):431-7 - PubMed
  16. Ann Oncol. 2009 Feb;20(2):379-85 - PubMed
  17. JAMA. 2004 Oct 6;292(13):1593-601 - PubMed
  18. Ann Intern Med. 2001 Jan 16;134(2):152-7 - PubMed
  19. Am J Clin Oncol. 2004 Dec;27(6):570-5 - PubMed
  20. CA Cancer J Clin. 2002 May-Jun;52(3):134-49 - PubMed
  21. Br J Haematol. 2000 Sep;110(3):620-30 - PubMed
  22. J Clin Oncol. 2004 Nov 1;22(21):4312-8 - PubMed
  23. Am J Med Sci. 1992 Dec;304(6):348-51 - PubMed

MeSH terms

Publication Types

Grant support